ATI (NYSE:ATI – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at Benchmark in a research report issued to clients and investors on Monday,Benzinga reports. They currently have a $81.00 price objective on the basic materials company’s stock. Benchmark’s target price would suggest a potential upside of 80.28% from the stock’s […]

Surgery Partners (NASDAQ:SGRY – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at Benchmark in a note issued to investors on Monday,Benzinga reports. They currently have a $35.00 price target on the stock. Benchmark’s price target indicates a potential upside of 74.69% from the company’s previous close. A number of other […]